Gracell Biotechnologies Probability of Future Stock Price Finishing Over 4.02
| GRCLDelisted Stock | USD 4.02 0.26 6.07% |
Gracell |
Gracell Biotechnologies Target Price Odds to finish over 4.02
The tendency of Gracell Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 4.02 | 90 days | 4.02 | about 29.2 |
Based on a normal probability distribution, the odds of Gracell Biotechnologies to move above the current price in 90 days from now is about 29.2 (This Gracell Biotechnologies probability density function shows the probability of Gracell Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.4 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Gracell Biotechnologies will likely underperform. Moreover Gracell Biotechnologies has an alpha of 1.2517, implying that it can generate a 1.25 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Gracell Biotechnologies Price Density |
| Price |
Predictive Modules for Gracell Biotechnologies
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Gracell Biotechnologies. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Gracell Biotechnologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Gracell Biotechnologies Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Gracell Biotechnologies is not an exception. The market had few large corrections towards the Gracell Biotechnologies' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Gracell Biotechnologies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Gracell Biotechnologies within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.25 | |
β | Beta against Dow Jones | 1.40 | |
σ | Overall volatility | 1.26 | |
Ir | Information ratio | 0.16 |
Gracell Biotechnologies Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Gracell Biotechnologies for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Gracell Biotechnologies can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Gracell Biotechnologies is not yet fully synchronised with the market data | |
| Gracell Biotechnologies has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (496.98 M) with profit before overhead, payroll, taxes, and interest of 366 K. | |
| Gracell Biotechnologies currently holds about 1.71 B in cash with (482.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 25.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 63.0% of the company shares are owned by institutional investors |
Gracell Biotechnologies Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Gracell Stock often depends not only on the future outlook of the current and potential Gracell Biotechnologies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Gracell Biotechnologies' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 107.5 M | |
| Cash And Short Term Investments | 1.5 B |
Gracell Biotechnologies Technical Analysis
Gracell Biotechnologies' future price can be derived by breaking down and analyzing its technical indicators over time. Gracell Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Gracell Biotechnologies. In general, you should focus on analyzing Gracell Stock price patterns and their correlations with different microeconomic environments and drivers.
Gracell Biotechnologies Predictive Forecast Models
Gracell Biotechnologies' time-series forecasting models is one of many Gracell Biotechnologies' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Gracell Biotechnologies' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Gracell Biotechnologies
Checking the ongoing alerts about Gracell Biotechnologies for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Gracell Biotechnologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Gracell Biotechnologies is not yet fully synchronised with the market data | |
| Gracell Biotechnologies has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (496.98 M) with profit before overhead, payroll, taxes, and interest of 366 K. | |
| Gracell Biotechnologies currently holds about 1.71 B in cash with (482.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 25.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 63.0% of the company shares are owned by institutional investors |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Gracell Stock
If you are still planning to invest in Gracell Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gracell Biotechnologies' history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |